Hancock Whitney’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.33M | Sell |
6,023
-56
| -0.9% | -$15.5K | 0.02% | 390 |
|
|
2026
Q1 | $1.75M | Buy |
6,079
+44
| +0.7% | +$13.1K | 0.03% | 333 |
|
|
2025
Q4 | $1.65M | Sell |
6,035
-515
| -8% | -$140K | 0.03% | 328 |
|
|
2025
Q3 | $1.77M | Buy |
6,550
+101
| +2% | +$27.5K | 0.03% | 322 |
|
|
2025
Q2 | $1.78M | Buy |
6,449
+126
| +2% | +$34.3K | 0.03% | 313 |
|
|
2025
Q1 | $1.68M | Hold |
6,323
| – | – | 0.05% | 239 |
|
|
2024
Q4 | $1.47M | Hold |
6,323
| – | – | 0.05% | 254 |
|
|
2024
Q3 | $1.4M | Buy |
6,323
+22
| +0.3% | +$4.55K | 0.05% | 255 |
|
|
2024
Q2 | $1.24M | Hold |
6,301
| – | – | 0.04% | 264 |
|
|
2024
Q1 | $1.36M | Sell |
6,301
-2
| -0% | -$420 | 0.05% | 255 |
|
|
2023
Q4 | $1.33M | Sell |
6,303
-221
| -3% | -$47.2K | 0.05% | 261 |
|
|
2023
Q3 | $1.31M | Sell |
6,524
-135
| -2% | -$26.8K | 0.05% | 244 |
|
|
2023
Q2 | $1.23M | Buy |
6,659
+179
| +3% | +$33.1K | 0.05% | 271 |
|
|
2023
Q1 | $1.24M | Buy |
6,480
+63
| +1% | +$11.4K | 0.05% | 269 |
|
|
2022
Q4 | $1.08M | Sell |
6,417
-2,564
| -29% | -$446K | 0.04% | 299 |
|
|
2022
Q3 | $1.59M | Sell |
8,981
-59
| -0.7% | -$11.7K | 0.07% | 226 |
|
|
2022
Q2 | $1.85M | Sell |
9,040
-173
| -2% | -$36.7K | 0.07% | 213 |
|
|
2022
Q1 | $2.19M | Buy |
9,213
+191
| +2% | +$44.9K | 0.07% | 208 |
|
|
2021
Q4 | $2.06M | Buy |
9,022
+72
| +0.8% | +$15.8K | 0.06% | 235 |
|
|
2021
Q3 | $1.73M | Sell |
8,950
-1,195
| -12% | -$242K | 0.06% | 253 |
|
|
2021
Q2 | $2.16M | Sell |
10,145
-35
| -0.3% | -$7.39K | 0.07% | 253 |
|
|
2021
Q1 | $2.08M | Buy |
10,180
+118
| +1% | +$23.2K | 0.07% | 265 |
|
|
2020
Q4 | $1.83M | Buy |
10,062
+1,346
| +15% | +$229K | 0.06% | 282 |
|
|
2020
Q3 | $1.46M | Sell |
8,716
-7,715
| -47% | -$1.3M | 0.05% | 290 |
|
|
2020
Q2 | $2.67M | Sell |
16,431
-2,902
| -15% | -$520K | 0.1% | 171 |
|
|
2020
Q1 | $3.34M | Buy |
19,333
+6,391
| +49% | +$1.27M | 0.13% | 174 |
|
|
2019
Q4 | $2.6M | Sell |
12,942
-83
| -0.6% | -$17K | 0.08% | 263 |
|
|
2019
Q3 | $2.75M | Sell |
13,025
-7,065
| -35% | -$1.48M | 0.09% | 255 |
|
|
2019
Q2 | $3.9M | Sell |
20,090
-26,163
| -57% | -$4.82M | 0.12% | 215 |
|
|
2019
Q1 | $7.61M | Sell |
46,253
-671
| -1% | -$119K | 0.24% | 123 |
|
|
2018
Q4 | $8.83M | Sell |
46,924
-2,623
| -5% | -$484K | 0.3% | 95 |
|
|
2018
Q3 | $8.43M | Buy |
+49,547
| New | +$8.34M | 0.24% | 146 |
|
Other funds holding CME
Hancock Whitney's CME Position: Q2 2026 in Review
Hancock Whitney reduced its CME Group (CME) stake by 0.92% in Q2 2026, selling an estimated $15.5K and leaving 6,023 shares worth $1.33M. The position accounts for 0.02% of the portfolio, ranked #390.
Hancock Whitney first reported a position in CME in Q3 2018 and has held it in 32 quarters since. The position peaked at $8.83M in Q4 2018. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Hancock Whitney held 6,023 shares of CME Group worth $1.33M as of Q2 2026.
- Hancock Whitney sold 56 CME Group shares in Q2 2026, an estimated $15.5K.
- CME Group made up 0.02% of Hancock Whitney's portfolio in Q2 2026, its #390 holding.
- Hancock Whitney first reported a position in CME Group in Q3 2018 and has held it in 32 quarters since.
- Hancock Whitney's CME Group position peaked at $8.83M in Q4 2018.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Hancock Whitney's 13F filing for Q2 2026, filed 14 Aug 2026.